J. Mariani

striatum regulatory network in the mouse receptor reveals an Egr-2-mediated 2A Aand pharmacological inactivation of adenosine

Z. Weng, Liqun Yu, Jiang-Fan Chen, 2005 .

Outcomes of a clinical pathway for primary outpatient management of pediatric patients with low‐risk febrile neutropenia

H. Weinstein, A. Friedmann, J. Mariani, 2019, Pediatric blood & cancer.

Selective inactivation or reconstitution of adenosine A2A receptors in bone marrow cells reveals their significant contribution to the development of ischemic brain injury

M. Moskowitz, Liqun Yu, Zhihong Huang, 2004, Nature Medicine.

Genetic and pharmacological inactivation of adenosine A2A receptor reveals an Egr-2-mediated transcriptional regulatory network in the mouse striatum.

Z. Weng, Liqun Yu, P. Haverty, 2005, Physiological genomics.

UBE4B promotes Hdm2-mediated degradation of the tumor suppressor p53

S. Pomeroy, K. Nakayama, L. Spyracopoulos, 2011, Nature Medicine.

Increased prevalence of unprovoked seizures in patients with a 22q11.2 deletion

E. Zackai, A. Brooks-Kayal, D. Lynch, 2004, American journal of medical genetics. Part A.

Genetic and pharmacological inactivation of adenosine A2A receptor reveals an Egr-2-mediated transcriptional regulatory network in the mouse striatum.

Z. Weng, Liqun Yu, M. Schwarzschild, 2005, Physiological genomics.